colorectal cancer tissues; adjacent non-cancerous colon tissues; cancer and adjacent non-cancerous colon tissues
HCT116; LO2; 293T; HeLa; A549; HepG2; HT29; U2OS; H1299; MCF7; Hep3B; HAFF
cell line-derived xenograft
glycolysis (promotes); lipid metabolism (other); proliferation (promotes); other pathway/process (promotes); ubiquitination (inhibits)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; Northern Blot; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; ChIP / ChIP-seq; Luciferase Reporter Assay; Transfection; Colony Formation Assay; In Vivo Animal Model; Western Blot; Bioinformatics Analysis
circACC1 expression is elevated in the majority of colorectal cancers and positively correlates with activated c-Jun, AMPK activation, and AMPK subunit levels in cancer tissues.
circACC1 is a human ACC1-derived circular RNA that is up-regulated in most colorectal cancer tissues examined. It is induced by c-Jun under serum deprivation and directly binds AMPK b1 and g1 subunits to promote AMPK holoenzyme assembly, stability, and activation. Through AMPK-dependent metabolic reprogramming, circACC1 promotes glycolysis, fatty acid oxidation, cancer cell proliferation, and xenograft tumor growth.
0.8621
CircACC1 Regulates Assembly and Activation of AMPK Complex under Metabolic Stress.
combined biological and clinical study